MENU
+Compare
SNY
Stock ticker: NASDAQ
AS OF
Oct 3 closing price
Price
$50.90
Change
+$0.76 (+1.52%)
Capitalization
124.01B

SNY Sanofi ADS Forecast, Technical & Fundamental Analysis

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases... Show more

SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SNY with price predictions
Oct 03, 2025

Momentum Indicator for SNY turns positive, indicating new upward trend

SNY saw its Momentum Indicator move above the 0 level on September 30, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned positive. In of the 99 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SNY just turned positive on October 01, 2025. Looking at past instances where SNY's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

SNY moved above its 50-day moving average on October 01, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNY advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for SNY crossed bearishly below the 50-day moving average on September 09, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SNY broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SNY entered a downward trend on October 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.511) is normal, around the industry mean (9.704). P/E Ratio (16.593) is within average values for comparable stocks, (24.419). Projected Growth (PEG Ratio) (0.785) is also within normal values, averaging (2.018). SNY has a moderately high Dividend Yield (0.043) as compared to the industry average of (0.027). P/S Ratio (2.362) is also within normal values, averaging (3.548).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SNY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SNY is expected to report earnings to rise 2.52% to $1.63 per share on October 24

Sanofi ADS SNY Stock Earnings Reports
Q3'25
Est.
$1.63
Q2'25
Beat
by $0.63
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.53
Q3'24
Beat
by $0.88
The last earnings report on July 31 showed earnings per share of $1.59, beating the estimate of 95 cents. With 3.73M shares outstanding, the current market capitalization sits at 124.01B.
A.I.Advisor
published Dividends

SNY paid dividends on June 12, 2025

Sanofi ADS SNY Stock Dividends
А dividend of $2.21 per share was paid with a record date of June 12, 2025, and an ex-dividend date of May 09, 2025. Read more...
A.I. Advisor
published General Information

General Information

a producer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
46, avenue de la Grande Armée
Phone
+33 153774000
Employees
87994
Web
https://www.sanofi.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PHYS29.860.24
+0.81%
Sprott Physical Gold Trust
PPTY31.010.10
+0.31%
Vident U.S. Diversified Real Estate ETF
FIRI19.010.04
+0.24%
FIRE Funds Income Target ETF
SDG84.590.07
+0.09%
iShares MSCI Global Sust Dev Goals ETF
PAXS16.400.01
+0.06%
PIMCO Access Income Fund

SNY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with SNYNF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then SNYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+1.52%
SNYNF - SNY
61%
Loosely correlated
+2.86%
GSK - SNY
54%
Loosely correlated
-0.78%
NVS - SNY
53%
Loosely correlated
+1.08%
PFE - SNY
53%
Loosely correlated
+1.07%
AZN - SNY
53%
Loosely correlated
+1.98%
More